In a blistering month for stocks, Aphria Inc. (NYSE: APHA) has had a particularly bumpy ride.
The Leamington, Canada--based cannabis company was the target of some particularly explosive allegations from, as it turns out, a firm with substantial short interest. This is a common enough occurrence in the stock market, as Carl Icahn and Bill Ackman's legendary "long vs. short" battle royale over Herbalife Nutrition Ltd. (NYSE: HLF) illustrates.
The short-seller's allegations focus only on Aphria and one other, small company: Toronto, Ont.--based SOL Global Investments Inc. (CNSX: SOL). They have nothing to do with other cannabis firms we follow at the National Institute for Cannabis Investors
Since the short attack and furious price action last week, I wanted everyone to know what's really happening with Aphria.
It's the truth you won't hear anywhere else - and a beautifully wrapped-up December buying opportunity...
Here Are 10 “One-Click” Ways to Earn 10% or Better on Your Money Every Quarter
Appreciation is great, but it’s possible to get even more out of the shares you own. A lot more: you can easily beat inflation and collect regular income to spare. There are no complicated trades to put on, no high-level options clearances necessary. In fact, you can do this with a couple of mouse clicks – passive income redefined. Click here for the report…
About the Author
Greg Miller started working on Wall Street in September, 1987, just a month before the “Black Monday” stock market crash.
During his career there, he became an expert in just about every kind of publicly traded security - from blue-chip and small-cap stocks to municipals, junk bonds, and derivatives. As a portfolio manager, Greg was responsible for over $500 million of assets in mutual funds and insurance company accounts.
After leaving the Street, he designed a successful options trading strategy and made lucrative tech investments for a financial publication. He has also helped develop new products and worked with other editors to hone their strategies. He’s always been dedicated to deep, fundamental research - and he always will be - because he believes buying the very best companies at the right price is the best way to amass wealth in the stock market.